Record Information |
---|
Version | 1.0 |
---|
Creation Date | 2016-05-19 04:38:23 UTC |
---|
Update Date | 2016-11-09 01:15:06 UTC |
---|
Accession Number | CHEM014903 |
---|
Identification |
---|
Common Name | 1,2,3-Propanetriol, homopolymer, dodecanoate |
---|
Class | Small Molecule |
---|
Description | |
---|
Contaminant Sources | - FooDB Chemicals
- HPV EPA Chemicals
|
---|
Contaminant Type | Not Available |
---|
Chemical Structure | |
---|
Synonyms | Value | Source |
---|
12:0 cholesterol ester | Lipid Annotator, HMDB | 1-dodecanoyl-cholesterol | Lipid Annotator, HMDB | cholesteryl 1-dodecanoate | Lipid Annotator, HMDB | Cholesterol Ester(12:0) | Lipid Annotator, HMDB | CE(12:0) | Lipid Annotator | CE(12:0/0:0) | Lipid Annotator, HMDB | cholesterol 1-dodecanoic acid | Lipid Annotator, HMDB | Cholesterol Ester(12:0/0:0) | Lipid Annotator, HMDB | cholesterol 1-dodecanoate | Lipid Annotator, HMDB | cholesteryl 1-dodecanoic acid | Lipid Annotator, HMDB | (3beta)-Cholest-5-en-3-ol dodecanoate | HMDB | (3beta)-Cholest-5-en-3-ol dodecanoic acid | HMDB | Cholest-5-en-3-beta-yl laurate | HMDB | Cholest-5-en-3-yl laurate | HMDB | Cholest-5-en-3b-ol dodecanoate | HMDB | Cholest-5-en-3b-ol dodecanoic acid | HMDB | Cholest-5-en-3beta-ol dodecanoate | HMDB | Cholest-5-en-3beta-ol dodecanoic acid | HMDB | Cholest-5-en-3beta-yl dodecanoate | HMDB | Cholest-5-en-3beta-yl dodecanoic acid | HMDB | Cholesterol laurate | HMDB | Cholesteryl dodecanoate | HMDB | Cholesteryl dodecanoic acid | HMDB | Cholesteryl laurate | HMDB | Cholesteryl lauric acid | HMDB | Dodecanoate | HMDB | Dodecanoic acid | HMDB | Dodecanoic acid cholesteryl ester | HMDB |
|
---|
Chemical Formula | C39H68O2 |
---|
Average Molecular Mass | 568.956 g/mol |
---|
Monoisotopic Mass | 568.522 g/mol |
---|
CAS Registry Number | 74504-64-6 |
---|
IUPAC Name | (1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl dodecanoate |
---|
Traditional Name | (1S,2R,5S,10S,11S,14R,15R)-2,15-dimethyl-14-[(2R)-6-methylheptan-2-yl]tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-yl dodecanoate |
---|
SMILES | [H][C@@]1(CC[C@@]2([H])[C@]3([H])CC=C4C[C@H](CC[C@]4(C)[C@@]3([H])CC[C@]12C)OC(=O)CCCCCCCCCCC)[C@H](C)CCCC(C)C |
---|
InChI Identifier | InChI=1S/C39H68O2/c1-7-8-9-10-11-12-13-14-15-19-37(40)41-32-24-26-38(5)31(28-32)20-21-33-35-23-22-34(30(4)18-16-17-29(2)3)39(35,6)27-25-36(33)38/h20,29-30,32-36H,7-19,21-28H2,1-6H3/t30-,32+,33+,34-,35+,36+,38+,39-/m1/s1 |
---|
InChI Key | RMLFYKFCGMSLTB-ZBDFTZOCSA-N |
---|
Chemical Taxonomy |
---|
Description | belongs to the class of organic compounds known as cholesteryl esters. Cholesteryl esters are compounds containing an esterified cholestane moiety. |
---|
Kingdom | Organic compounds |
---|
Super Class | Lipids and lipid-like molecules |
---|
Class | Steroids and steroid derivatives |
---|
Sub Class | Steroid esters |
---|
Direct Parent | Cholesteryl esters |
---|
Alternative Parents | |
---|
Substituents | - Cholesteryl ester
- Cholesterol
- Cholestane-skeleton
- Delta-5-steroid
- Carboxylic acid ester
- Monocarboxylic acid or derivatives
- Carboxylic acid derivative
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Carbonyl group
- Aliphatic homopolycyclic compound
|
---|
Molecular Framework | Aliphatic homopolycyclic compounds |
---|
External Descriptors | |
---|
Biological Properties |
---|
Status | Detected and Not Quantified |
---|
Origin | Not Available |
---|
Cellular Locations | Not Available |
---|
Biofluid Locations | Not Available |
---|
Tissue Locations | Not Available |
---|
Pathways | Not Available |
---|
Applications | Not Available |
---|
Biological Roles | Not Available |
---|
Chemical Roles | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Appearance | Not Available |
---|
Experimental Properties | Property | Value |
---|
Melting Point | Not Available | Boiling Point | Not Available | Solubility | Not Available |
|
---|
Predicted Properties | |
---|
Spectra |
---|
Spectra | Spectrum Type | Description | Splash Key | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - GC-MS (Non-derivatized) - 70eV, Positive | splash10-0pdr-5609470000-6b60469492de6fcfcb73 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-014i-1604190000-6706072027e7de784787 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-0apr-5809220000-e29ff21098d1115f6bdd | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-0a6r-6509100000-2af4552a7f5c424a8cd0 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-014i-0204090000-59a71753bafb5dd77950 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-00kr-0409130000-0276872bfeca99f8bee5 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-015l-2209000000-d9773980e2464716378f | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-014i-0000090000-6b3ff25055c5f35452d9 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-00lr-1901060000-cd48e20184f7182b334c | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-0aou-1900010000-847c75ab2ee5f4fbb09b | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-014i-6114090000-3f242879e2b48e461f02 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-0a4l-9210110000-b21df826281dc25f7274 | Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-052f-9200100000-1cb56240b10f124a25c7 | Spectrum | 1D NMR | 1H NMR Spectrum | Not Available | Spectrum | 1D NMR | 13C NMR Spectrum | Not Available | Spectrum |
|
---|
Toxicity Profile |
---|
Route of Exposure | Not Available |
---|
Mechanism of Toxicity | Not Available |
---|
Metabolism | Not Available |
---|
Toxicity Values | Not Available |
---|
Lethal Dose | Not Available |
---|
Carcinogenicity (IARC Classification) | Not Available |
---|
Uses/Sources | Not Available |
---|
Minimum Risk Level | Not Available |
---|
Health Effects | Not Available |
---|
Symptoms | Not Available |
---|
Treatment | Not Available |
---|
Concentrations |
---|
| Not Available |
---|
External Links |
---|
DrugBank ID | Not Available |
---|
HMDB ID | HMDB0002262 |
---|
FooDB ID | FDB022932 |
---|
Phenol Explorer ID | Not Available |
---|
KNApSAcK ID | Not Available |
---|
BiGG ID | Not Available |
---|
BioCyc ID | Not Available |
---|
METLIN ID | Not Available |
---|
PDB ID | Not Available |
---|
Wikipedia Link | Not Available |
---|
Chemspider ID | 92314 |
---|
ChEBI ID | Not Available |
---|
PubChem Compound ID | 102182 |
---|
Kegg Compound ID | C02530 |
---|
YMDB ID | YMDB16149 |
---|
ECMDB ID | Not Available |
---|
References |
---|
Synthesis Reference | Not Available |
---|
MSDS | Not Available |
---|
General References | 1. Mensink RP, Zock PL, Kester AD, Katan MB: Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr. 2003 May;77(5):1146-55. | 2. Temme EH, Mensink RP, Hornstra G: Comparison of the effects of diets enriched in lauric, palmitic, or oleic acids on serum lipids and lipoproteins in healthy women and men. Am J Clin Nutr. 1996 Jun;63(6):897-903. | 3. Lagrost L, Mensink RP, Guyard-Dangremont V, Temme EH, Desrumaux C, Athias A, Hornstra G, Gambert P: Variations in serum cholesteryl ester transfer and phospholipid transfer activities in healthy women and men consuming diets enriched in lauric, palmitic or oleic acids. Atherosclerosis. 1999 Feb;142(2):395-402. |
|
---|